Consumer Staples [ 4/12 ] | Personal Care Products [ 44/75 ]
NYSE | Common Stock
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America.
It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health.
The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements.
It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands.
Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Feb 17, 26 | 0.27 Increased by +3.85% | 0.22 Increased by +22.73% |
| Nov 3, 25 | 0.28 Increased by 0.00% | 0.26 Increased by +7.69% |
| Aug 7, 25 | 0.22 Decreased by -31.25% | 0.24 Decreased by -8.33% |
| May 8, 25 | 0.24 Decreased by -14.29% | 0.23 Increased by +4.35% |
| Feb 6, 25 | 0.26 Decreased by -16.13% | 0.26 |
| Nov 7, 24 | 0.28 Decreased by -9.68% | 0.27 Increased by +3.70% |
| Aug 6, 24 | 0.32 Increased by 0.00% | 0.28 Increased by +14.29% |
| May 7, 24 | 0.28 Increased by +47.37% | 0.25 Increased by +12.00% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 25 | 3.78 B Increased by +3.22% | 330.00 M Increased by +12.63% | Increased by +8.73% Increased by +9.11% |
| Sep 30, 25 | 3.76 B Decreased by -3.46% | 398.00 M Increased by +3.92% | Increased by +10.57% Increased by +7.64% |
| Jun 30, 25 | 3.84 B Decreased by -4.03% | 420.00 M Increased by +624.14% | Increased by +10.94% Increased by +654.51% |
| Mar 31, 25 | 3.74 B Decreased by -3.93% | 322.00 M Increased by +8.78% | Increased by +8.61% Increased by +13.23% |
| Dec 31, 24 | 3.66 B Decreased by -0.11% | 293.00 M Decreased by -10.40% | Increased by +8.00% Decreased by -10.30% |
| Sep 30, 24 | 3.90 B Decreased by -0.41% | 383.00 M Decreased by -12.56% | Increased by +9.82% Decreased by -12.20% |
| Jun 30, 24 | 4.00 B Decreased by -0.27% | 58.00 M Decreased by -86.51% | Increased by +1.45% Decreased by -86.47% |
| Mar 31, 24 | 3.89 B Increased by +1.09% | 296.00 M Decreased by -36.89% | Increased by +7.60% Decreased by -37.57% |